{"url_path":"/sec/clov/8-k/2026-05-18/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1801170/0001801170-26-000128-index.html","accession_number":"0001801170-26-000128","cik":"0001801170","ticker":"CLOV","issuer_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","edgar_url":"https://www.sec.gov/Archives/edgar/data/1801170/0001801170-26-000128-index.html","primary_entity_key":"0001801170","primary_entity_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE"},"word_count":82,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) List of Exhibits\n\nExhibit No.Description\n\n99.1\n[Press Release of the Company, dated May 18, 2026](ax1q26supplementalqaex99.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nClover Health Investments, Corp.\n\nDate:May 18, 2026By:/s/ Clay Thornton\n\nName:Clay Thornton\n\nTitle:Interim Chief Financial Officer (Principal Financial Officer)"}